Littérature scientifique sur le sujet « Lysosomal storage diseases »

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Lysosomal storage diseases ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Articles de revues sur le sujet "Lysosomal storage diseases"

1

Xu, Miao, Ke Liu, Manju Swaroop, et al. "A Phenotypic Compound Screening Assay for Lysosomal Storage Diseases." Journal of Biomolecular Screening 19, no. 1 (2013): 168–75. http://dx.doi.org/10.1177/1087057113501197.

Texte intégral
Résumé :
The lysosome is a vital cellular organelle that primarily functions as a recycling center for breaking down unwanted macromolecules through a series of hydrolases. Functional deficiencies in lysosomal proteins due to genetic mutations have been found in more than 50 lysosomal storage diseases that exhibit characteristic lipid/macromolecule accumulation and enlarged lysosomes. Recently, the lysosome has emerged as a new therapeutic target for drug development for the treatment of lysosomal storage diseases. However, a suitable assay for compound screening against the diseased lysosomes is curre
Styles APA, Harvard, Vancouver, ISO, etc.
2

Schulze, M., S. Groeschel, J. Gburek-Augustat, T. Nägele, and M. Horger. "Lysosomal Storage Diseases – Lysosomale Speichererkrankungen." RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 187, no. 12 (2015): 1057–60. http://dx.doi.org/10.1055/s-0035-1552368.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Simonaro, Calogera M. "Lysosomes, Lysosomal Storage Diseases, and Inflammation." Journal of Inborn Errors of Metabolism and Screening 4 (May 14, 2016): 232640981665046. http://dx.doi.org/10.1177/2326409816650465.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Breiden, Bernadette, and Konrad Sandhoff. "Lysosomal Glycosphingolipid Storage Diseases." Annual Review of Biochemistry 88, no. 1 (2019): 461–85. http://dx.doi.org/10.1146/annurev-biochem-013118-111518.

Texte intégral
Résumé :
Glycosphingolipids are cell-type-specific components of the outer leaflet of mammalian plasma membranes. Gangliosides, sialic acid–containing glycosphingolipids, are especially enriched on neuronal surfaces. As amphi-philic molecules, they comprise a hydrophilic oligosaccharide chain attached to a hydrophobic membrane anchor, ceramide. Whereas glycosphingolipid formation is catalyzed by membrane-bound enzymes along the secretory pathway, degradation takes place at the surface of intralysosomal vesicles of late endosomes and lysosomes catalyzed in a stepwise fashion by soluble hydrolases and as
Styles APA, Harvard, Vancouver, ISO, etc.
5

Gorbunova, Victoria N. "Congenital metabolic diseases. Lysosomal storage diseases." Pediatrician (St. Petersburg) 12, no. 2 (2021): 73–83. http://dx.doi.org/10.17816/ped12273-83.

Texte intégral
Résumé :
The classification and epidemiology of hereditary metabolic disorders are presented. That is a large group consisting from more them 800 monogenic diseases, each of which caused by inherited deficiency of certain metabolic fate. Many of these disorders are extremely rare, but their total incidence in the population is close to 1:10005000. Lysosomal storage diseases (LSD) resulting from inherited deficiency in lysosomal functions occupy a special place among hereditary metabolic disorders. The defects of catabolism cause the accumulation of undigested or partially digested macromolecules in lys
Styles APA, Harvard, Vancouver, ISO, etc.
6

Gorbunova, Viktoria N., Natalia V. Buchinskaia, and Anastasia O. Vechkasova. "Lysosomal storage diseases. Mucolipidosis." Pediatrician (St. Petersburg) 15, no. 5 (2024): 81–98. https://doi.org/10.17816/ped15581-98.

Texte intégral
Résumé :
The epidemiology, clinical, biochemical and molecular genetic characteristics of mucolipidoses — autosomal recessive lysosomal storage diseases that combine the clinical manifestations of mucopolysaccharidoses and sphingolipidoses — are presented. In accordance with the modern classification, types I, II and III mucolipidoses are classified as glycoproteinoses, and type IV mucolipidoses are classified as gangliosidoses. Mucolipidoses type I, or sialidosis, is caused by the presence of inactivating mutations in the α-neuraminidase gene NEU1, and a related disease is galactosialidosis, accompani
Styles APA, Harvard, Vancouver, ISO, etc.
7

Gorbunova, Victoria N., Natalia V. Buchinskaia, and Anastasia O. Vechkasova. "Lysosomal storage diseases. Glycoproteinoses — oligosaccharidoses." Pediatrician (St. Petersburg) 16, no. 1 (2025): 5–24. https://doi.org/10.17816/ped1615-24.

Texte intégral
Résumé :
The epidemiology, clinical, biochemical and molecular genetic characteristics of oligosaccharidoses are presented — a group of rare autosomal recessive lysosomal diseases, includes sialidosis, mannosidosis, fucosidosis, aspartylglucosaminuria and α-N-acetylgalactosaminidase deficiency. All these diseases are caused by impaired catabolism of glycoproteins and excessive accumulation of various types of oligosaccharides in lysosomes. Clinically, they are characterized by progressive neuropsychiatric disorders combined with a mild gurler-like phenotype. Two genetically heterogeneous variants of al
Styles APA, Harvard, Vancouver, ISO, etc.
8

Ferreira, Carlos R., and William A. Gahl. "Lysosomal storage diseases." Translational Science of Rare Diseases 2, no. 1-2 (2017): 1–71. http://dx.doi.org/10.3233/trd-160005.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Rose Georgy, Smitha. "Lysosomal storage diseases." Journal of Veterinary and Animal Sciences 52, no. 1 (2021): 1–6. http://dx.doi.org/10.51966/jvas.2021.52.1.1-6.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

Neufeld, Elizabeth F. "Lysosomal Storage Diseases." Annual Review of Biochemistry 60, no. 1 (1991): 257–80. http://dx.doi.org/10.1146/annurev.bi.60.070191.001353.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
Plus de sources

Thèses sur le sujet "Lysosomal storage diseases"

1

Roy, Elise. "Cell disorders in lysosomal storage diseases." Phd thesis, Université René Descartes - Paris V, 2012. http://tel.archives-ouvertes.fr/tel-00683248.

Texte intégral
Résumé :
Mucopolysaccharidosis type IIIB (MPSIIIB) is a lysosomal storage disease (LSD) characterized by accumulation of heparan sulfate oligosaccharides (HSO), which results in progressive mental retardation, neurodegeneration and premature death in children. The underlying mechanisms are poorly understood. Coming to a better understanding of the pathophysiology of MPSIIIB has become a necessity to assess the efficacy of gene therapy treatment regarding loss of neuronal plasticity, and to define the best conditions for treatment. To address the link between HSO accumulation and downstream pathological
Styles APA, Harvard, Vancouver, ISO, etc.
2

Chen, Chun-Wu. "Defective iron homeostasis in lysosomal storage diseases." Thesis, University of Oxford, 2013. http://ora.ox.ac.uk/objects/uuid:5127c241-be64-4990-bef5-70e15d391394.

Texte intégral
Résumé :
Niemann-Pick type Cl (NPC1) disease is a neurodegenerative lysosomal storage disorder characterized by the accumulation of multiple lipids in the late endosome/lysosomal system and reduced acidic store calcium levels. Since the lysosomal system is involved in regulating aspects of transition metal ion homeostasis and its intracellular compartmentalization, we have investigated whether there are metal ion metabolism defects and haematological abnormalities in NPC1 disease. We have identified multiple haematological changes, including decreased haematocrit, haemoglobin and mean corpuscular haemo
Styles APA, Harvard, Vancouver, ISO, etc.
3

Ross, Colin J. D. "Immuno-isolation gene therapy for lysosomal storage disease /." *McMaster only, 2001.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Rigal, Nathalie [Verfasser]. "Improving enzyme replacement therapy for lysosomal storage diseases / Nathalie Rigal." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2018. http://d-nb.info/115576093X/34.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Lewis, Martin David. "Human lysosomal sulphate transport." Title page, contents and abstract only, 2001. http://web4.library.adelaide.edu.au/theses/09PH/09phl6752.pdf.

Texte intégral
Résumé :
Addendum inserted at back Includes bibliographical references (leaves 266-287). 1. Introduction -- 2. Materials and general methods -- 3. Characterisation and partial purification of the lysosomal sulphate transporter -- 4. Identification of proteins involved in lysosomal sulphate transport -- 5. The relationship between a sulphate anion transporter family and the lysosomal sulphate transporter -- 6. Investigation of sulphate transport in human skin fibroblasts -- 7. Concluding remarks
Styles APA, Harvard, Vancouver, ISO, etc.
6

Kanju, Patrick M. Suppiramaniam Vishnu. "Synaptic glutamate receptor dysfunction in tissue and animal models of Alzheimer's disease." Auburn, Ala., 2005. http://repo.lib.auburn.edu/2005%20Summer/doctoral/KANJU_PATRICK_11.pdf.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

Champigny, Marc J. Igdoura Suleiman. "Transcriptional regulation of neu1 expression: Implications for lysosomal storage disease /." *McMaster only, 2005.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Maalouf, Katia Ghandour [Verfasser]. "Role of lipid rafts in the pathophysiology of lysosomal storage diseases / Katia Ghandour Maalouf." Hannover : Technische Informationsbibliothek und Universitätsbibliothek Hannover (TIB), 2012. http://nbn-resolving.de/urn:nbn:de:gbv:089-7259318337.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Ghandour, Maalouf Katia [Verfasser]. "Role of lipid rafts in the pathophysiology of lysosomal storage diseases / Katia Ghandour Maalouf." Hannover : Technische Informationsbibliothek und Universitätsbibliothek Hannover (TIB), 2012. http://d-nb.info/1029515352/34.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

Gray, James Andrew Russell. "Modulating the heat-shock response : a potential therapy for lysosomal storage disorders." Thesis, University of Oxford, 2014. https://ora.ox.ac.uk/objects/uuid:d9b746c9-9026-4a6e-97b5-00bb848100d7.

Texte intégral
Résumé :
Lysosomal storage disorders (LSDs) comprise a broad disease group of inherited metabolic disorders, the majority of which are associated with CNS pathology, significant disability and reductions in life expectancy. LSDs are caused by mutations in genes encoding proteins critical for the correct functioning of lysosomal homeostasis. The disruption of lysosomal homeostasis results in the abnormal accumulation of lysosomal content, initiating intracellular pathological events, including calcium dysregulation and lysosomal membrane permeablisation (LMP) affecting cell function and inducing cellula
Styles APA, Harvard, Vancouver, ISO, etc.
Plus de sources

Livres sur le sujet "Lysosomal storage diseases"

1

A, Barranger John, and Cabrera-Salazar Mario A, eds. Lysosomal storage disorders. Springer, 2007.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

Mehta, Atul B., and Bryan Winchester. Lysosomal storage disorders: A practical guide. Wiley-Blackwell, 2013.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Mononen, Ilkka. Lysosomal storage disease--aspartylglycosaminuria. Springer, 1997.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Inc, ebrary, ed. Lysosomal storage disorders: Principles and practice. World Scientific, 2010.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Boelens, Jaap Jan, and Robert Wynn, eds. Stem Cell Therapy in Lysosomal Storage Diseases. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-8357-1.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

A, Gibbs Dorothy, ed. Lysosomal storage diseases: Biochemical and clinical aspects. Taylor & Francis, 1986.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

G, Thoene Jess, ed. Pathophysiology of lysosomal transport. CRC Press, 1992.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Al-Essa, Mohammed A. Atlas of common lysosomal and peroxisomal disorders. Scientific Informations Office, Research Centre, King Faisal Specialist Hospital and Research Centre, 1999.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Beck, M., Deborah Elstein, and Gheona Altarescu. Fabry disease. Springer, 2010.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

1935-, Graucob E., ed. Hematologic cytology of storage diseases. Springer-Verlag, 1985.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
Plus de sources

Chapitres de livres sur le sujet "Lysosomal storage diseases"

1

Ozand, Pinar T., and Mohammed Al-Essa. "Lysosomal Storage Diseases." In Textbook of Clinical Pediatrics. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-02202-9_39.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

Ferns, Janis M., and Stephen H. Halpern. "Lysosomal Storage Diseases." In Consults in Obstetric Anesthesiology. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-59680-8_98.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Pastores, Gregory M. "Lysosomal Storage Diseases." In Neurochemical Mechanisms in Disease. Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-7104-3_23.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Imam, Ibrahim. "Lysosomal storage diseases." In 700 Essential Neurology Checklists. CRC Press, 2021. http://dx.doi.org/10.1201/9781003221258-99.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Winchester, Bryan. "Classification of Lysosomal Storage Diseases." In Lysosomal Storage Disorders. John Wiley & Sons, Ltd, 2012. http://dx.doi.org/10.1002/9781118514672.ch5.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

O'Rourke, Erin, Dawn Laney, Cindy Morgan, Kim Mooney, and Jennifer Sullivan. "Genetic Counseling for Lysosomal Storage Diseases." In Lysosomal Storage Disorders. Springer US, 2007. http://dx.doi.org/10.1007/978-0-387-70909-3_13.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

Kent, Alastair, Christine Lavery, and Jeremy Manuel. "The Patient Perspective on Rare Diseases." In Lysosomal Storage Disorders. John Wiley & Sons, Ltd, 2012. http://dx.doi.org/10.1002/9781118514672.ch24.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Winchester, Bryan. "Laboratory Diagnosis of Lysosomal Storage Diseases." In Lysosomal Storage Disorders. John Wiley & Sons, Ltd, 2012. http://dx.doi.org/10.1002/9781118514672.ch3.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Brady, Roscoe O. "The Concept of Treatment in Lysosomal Storage Diseases." In Lysosomal Storage Disorders. Springer US, 2007. http://dx.doi.org/10.1007/978-0-387-70909-3_3.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

de Duve, Christian. "From Lysosomes to Storage Diseases and Back: A Personal Reminiscence." In Lysosomal Storage Disorders. Springer US, 2007. http://dx.doi.org/10.1007/978-0-387-70909-3_1.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.

Actes de conférences sur le sujet "Lysosomal storage diseases"

1

Giugliano, Giusy, Michela Schiavo, Daniele Pirone, et al. "Investigation on lysosomal accumulation by a quantitative analysis of 2D phase-maps in digital holography microscopy." In Digital Holography and Three-Dimensional Imaging. Optica Publishing Group, 2024. http://dx.doi.org/10.1364/dh.2024.th2a.6.

Texte intégral
Résumé :
Quantitative Phase Imaging through Digital Holography (QPI-DH) represents a quantitative and label-free method to detect lysosomal dysfunction in cells. Testing in the cellular model of Mucopolysaccharidosis type III-A, a lysosomal storage disease, demonstrate its potential.
Styles APA, Harvard, Vancouver, ISO, etc.
2

Krželj, Vjekoslav, and Ivana Čulo Čagalj. "INHERITED METABOLIC DISORDERS AND HEART DISEASES." In Symposium with International Participation HEART AND … Akademija nauka i umjetnosti Bosne i Hercegovine, 2019. http://dx.doi.org/10.5644/pi2019.181.02.

Texte intégral
Résumé :
Inherited metabolic disorders can cause heart diseases, cardiomyopathy in particular, as well as cardiac arrhythmias, valvular and coronary diseases. More than 40 different inherited metabolic disorders can provoke cardiomyopathy, including lysosomal storage disorders, fatty acid oxidation defects, organic acidemias, amino acidopathies, glycogen storage diseases, congenital disorders of glycosylation as well as peroxisomal and mitochondrial disorders. If identified and diagnosed on time, some of congenital metabolic diseases could be successfully treated. It is important to assume them in case
Styles APA, Harvard, Vancouver, ISO, etc.
3

Medina, Diego. "Combining high-content imaging and repurposing of approved drugs to tackle lysosomal storage diseases." In Optical Methods for Inspection, Characterization, and Imaging of Biomaterials VI, edited by Pietro Ferraro, Simonetta Grilli, and Demetri Psaltis. SPIE, 2023. http://dx.doi.org/10.1117/12.2675267.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Alblooshi, Afaf, Abdul-Kader Souid, and Fatma Al Jasmi. "The Usefulness of Forced Oscillation Technique to assess lung functions in Patients with Lysosomal Storage Diseases." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa2413.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Decker, Christine, Katharina Kranz, Kristine Adam, Charlotte Thiels, Cornelia Köhler, and Thomas Lücke. "P 326. Developments in Stem Cell Transplantation in Lysosomal Storage Diseases—An Update on the Example of Mucopolysaccharidoses." In Abstracts of the 44th Annual Meeting of the Society for Neuropediatrics. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1676012.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

Guimarães, Matheus Procópio, Isabella Cristina Muniz Honorato, Diógenes Emanuel Dantas da Silva, et al. "A 26-year-old woman presenting with a history of epileptic crisis, ataxia and cognitive impairment." In XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.645.

Texte intégral
Résumé :
A 26-year-old woman was referred to a neurology outpatient clinic due to a 9-month history of generalized tonic-clonic seizures, gradually more frequent since onset. She additionally reports developing insidiously over four years ago, an asymmetrical tremor in the upper limbs (worse on the right hand), difficulty walking, speech disorders and decreased visual acuity on the right eye. She had a past medical history of major depressive disorder, but normal neuropsychomotor development in childhood, and did not drink alcohol or smoke tobacco. There is no family history of neurological conditions
Styles APA, Harvard, Vancouver, ISO, etc.
Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!